Sandford D. Smith, Exe VP, President Int'l Group at GENZYME CORP (GENZ), sold 3,359 shares at $58.90 ($198K) on 2010-03-19, disclosed to the SEC on 2010-03-23.
Scheduled sale ($198k) by Exe VP, President Int'l Group under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2021-11-19 | $1.4M | — | Filing → |
| CYTK | SELL | 2021-07-21 | $403K | — | Filing → |
| CYTK | SELL | 2021-04-27 | $135K | — | Filing → |